Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT04570423

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • New York Medical College Valhalla, New York, United States
  • Carolinas Medical Center/ Levine Children's Hospital Charlotte, North Carolina, United States
  • Levine Children's Health Charlotte, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

NCT05322850

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, +29 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View Trial Details
Recruiting

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

NCT05272826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • NL Health Services St. John's, Newfoundland and Labrador, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT05237986

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children s Hospital of Los Angeles Los Angeles, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Seattle Children s Hospital Seattle, Washington, United States
View Trial Details
Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

NCT06500273

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
View all 83 locations
View Trial Details
Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Hematology Oncology of Indiana Indianapolis, Indiana, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details

Related conditions